IPP Bureau

Aptar appoints Julie Xing to its Board of Directors
Aptar appoints Julie Xing to its Board of Directors

By IPP Bureau - March 07, 2023

Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.

Krsnaa Diagnostics completes Punjab Project
Krsnaa Diagnostics completes Punjab Project

By IPP Bureau - March 06, 2023

The company operates 25 CT Scanners, 6 new MRI Machines, 30 Pathological Laboratories, 1 Referral Laboratory, and 95 Collection Centers

Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution

By IPP Bureau - March 06, 2023

Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US

Aster DM Healthcare appoints Purana H Deepti as Additional Director
Aster DM Healthcare appoints Purana H Deepti as Additional Director

By IPP Bureau - March 06, 2023

She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.

Par Drugs and Chemicals receives WHO-GMP certificate
Par Drugs and Chemicals receives WHO-GMP certificate

By IPP Bureau - March 06, 2023

The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3

Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent

By IPP Bureau - March 06, 2023

This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry

Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments
Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments

By IPP Bureau - March 04, 2023

The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients

Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection
Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection

By IPP Bureau - March 04, 2023

Rocuronium Bromide Injection is a neuromuscular blocking agent

Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution

By IPP Bureau - March 04, 2023

Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States

Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi
Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi

By IPP Bureau - March 04, 2023

Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme

Sonowal inaugurates SCO’s first international conference on traditional medicine
Sonowal inaugurates SCO’s first international conference on traditional medicine

By IPP Bureau - March 04, 2023

The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

By IPP Bureau - March 03, 2023

Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event

Merck and AstraZeneca updates on US regulatory review of Lynparza for mCRPC
Merck and AstraZeneca updates on US regulatory review of Lynparza for mCRPC

By IPP Bureau - March 03, 2023

AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.

ProBioGen’s growth strategy continues successfully
ProBioGen’s growth strategy continues successfully

By IPP Bureau - March 03, 2023

Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team

Vaishali Pharma bags Rs 600 crore order for antibiotics pharmaceutical products
Vaishali Pharma bags Rs 600 crore order for antibiotics pharmaceutical products

By IPP Bureau - March 03, 2023

This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.

Latest Stories

Interviews

Packaging